Ipca Laboratories Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No. 65, 99 and 126, Danudyog Industrial Estate, Piparia, Silvassa, U.T. of Dadra and Nagar Haveli and Daman and Diu 396230, India (IND)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3005977675 · DUNS 918917303
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-04-26
- OAIDrug Quality Assurance2019-08-23
- OAIDrug Quality Assurance2014-12-19
- VAIDrug Quality Assurance2012-07-31
- VAIDrug Quality Assurance2010-05-28
Drugs this plant is listed as making
5 distinct drugs across 14 products name this site in their FDA label.
- AtenololIpca Laboratories Limited
- Furosemidein shortageIpca Laboratories Limited
- Hydroxychloroquine SulfateIpca Laboratories Limited
- OndansetronIpca Laboratories Limited
- Propranolol Hydrochloridein shortageIpca Laboratories Limited
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.